Dr Ricchiuti joined Labcorp in Dublin, OH as laboratory director and discipline director in immunology in 2015. Prior, Dr Ricchiuti was director of clinical chemistry (including immunology testing) and toxicology at the University of Cincinnati Medical Center (UCMC), and associate professor at the University of Cincinnati, Department of Pathology and Laboratory Medicine at the College of Medicine, in Cincinnati, OH (2012-2015). Dr Ricchiuti was the senior director of clinical biomarkers at Medpace Reference Laboratories, in Cincinnati, OH (2011-2012). Dr Ricchiuti was head of specialty assays immunology and clinical research laboratories at Brigham and Women's Hospital (BWH) and Harvard Medical School (HMS), Boston, MA (1999-2011). From 2008-2011, he was also the director of Harvard Catalyst Central Laboratories, formerly National Institute of Health-Clinical Research and Translational Medicine Center. During 1999-2008, he was also the director of the General Clinical Research Center (GCRC) Core Laboratories at the BWH. Dr Ricchiuti was associate biochemist in the endocrinology, diabetes and hypertension division and esoteric immunology assays, and was a faculty in medicine at HMS.
Over the course of his career, Dr Ricchiuti has aided in growing the clinical laboratory tests menu for chemistry and immunology esoteric assays; his responsibilities have included supervision of validation and implementation of new assays and technologies. He has overseen daily operations of the laboratories, as well as the quality assurance program for clinical chemistry, toxicology, point of care testing, immunology, and serology sections of clinical laboratory. As a faculty member, he trained the next generation of pathologists, medical and graduate students in clinical science and laboratory medicine. His earlier research focused on rheumatology biomarkers and more recent research focused on investigating cardiovascular risk factors. Dr Ricchiuti is involved in AACC national and local section and was chair of the Northeast division of the AACC during his time in Boston. In 2010, Dr Ricchiuti founded the Clinical Translational Science (CTS) division of the AACC and was chair of the AACC Ohio Valley Section.
Dr Ricchiuti obtained his doctorate degree in immunology in 1995 at University Louis Pasteur, Strasbourg, France, followed by a research fellowship and clinical chemistry, and clinical toxicology fellowship (ComACC program) at Hennepin County Medical Center (HCMC), Minneapolis, MN a combined program with Mayo Clinic, Rochester, MN.